Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CEUS vs CT/MRI for HCC post-TACE
NCT04569799Phase 4Completed
- Sponsor
- Penn State Health Milton S. Hershey Medical Center
- Start
- Oct 2020
- Primary completion
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sulfur hexafluoride in hepatocellular carcinoma (HCC), sponsored by Penn State Health Milton S. Hershey Medical Center. Started Oct 2020; status: completed.
02
Drugs
sulfur hexafluoride
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT04569799.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04569799.